ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DION GALLANT MD

8200 CONSTITUTION PL NE STE A PMG KASEMAN FAMILY HEALTHCARE

Albuquerque | New Mexico | 87110

(505) 291-2402

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,891Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 559

$359K Total Retail Price of All Prescriptions

Rank: 86 out of 559

446 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,666 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 424 382 1 2
SIMVASTATIN 305 285 2 3
LISINOPRIL 251 219 3 1
HYDROCODONE-ACETAMINOPHEN 208 193 S3 4 7
AMLODIPINE BESYLATE 205 180 5 6
CITALOPRAM HBR 191 171 6 21
OMEPRAZOLE 191 135 6 4
ZOLPIDEM TARTRATE 185 148 8 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 162 9 18
METFORMIN HCL 145 118 10 5
LOVASTATIN 145 132 10 10
METOPROLOL SUCCINATE 140 129 12 16
GABAPENTIN 121 72 13 9
FLUTICASONE PROPIONATE 108 96 14 22
TAMSULOSIN HCL 103 102 15 25
TRAMADOL HCL 94 56 16 27
ATORVASTATIN CALCIUM 94 76 16 20
ALENDRONATE SODIUM 88 88 18 13
TRAZODONE HCL 85 74 19 28
ALLOPURINOL 84 72 20 34
METOPROLOL TARTRATE 81 40 21 12
FINASTERIDE 80 74 22 59
HYDROCHLOROTHIAZIDE 76 74 23 8
FUROSEMIDE 75 53 24 11
FLUOXETINE HCL 75 45 24 37
METFORMIN HCL ER 71 64 26 75
CRESTOR 69 66 27 33
PANTOPRAZOLE SODIUM 69 56 27 41
PROAIR HFA 67 51 29 29
DOXAZOSIN MESYLATE 65 65 30 43
SYNTHROID 63 63 31 64
LOSARTAN POTASSIUM 60 55 32 14
SERTRALINE HCL 60 60 32 19
WARFARIN SODIUM 60 52 32 24
RANITIDINE HCL 54 39 35 26
ATENOLOL 53 51 36 15
LOSARTAN-HYDROCHLOROTHIAZIDE 51 51 37 52
OXYCODONE-ACETAMINOPHEN 50 24 S2 38 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.